
Chi Van Dang - Wikipedia
Chi Van Dang is a hematological oncologist and researcher, currently serving as the Scientific Director of Ludwig Institute for Cancer Research. [1] He is known for his research on genetics, …
Dr. Chi Van Dang, MD, PhD - Hopkins Medicine
Chi Van Dang is the Scientific Director of the Ludwig Institute for Cancer Research and Bloomberg Distinguished Professor of Cancer Medicine at Johns Hopkins. He is a physician …
Chi V. Dang, MD, PhD - Hopkins Medicine
The Dang lab contributed to defining the function of the MYC oncogene including establishing the first mechanistic link between MYC and cellular energy metabolism. This foundational concept …
Chi Van Dang, MD, PhD - Ludwig Cancer Research
Chi Van Dang, MD, PhD CEO and Scientific Director I oversee the execution of Ludwig’s scientific strategy, with a special focus on the operations and staffing of the Lausanne, Oxford and …
Chi Van Dang - Ludwig Cancer Research
2018年4月4日 · Ludwig Scientific Director Chi Van Dang has worked to unravel how the oncogene MYC links the aberrant metabolism of cancer cells to their unchecked proliferation.
Chi Van Dang - Johns Hopkins Bloomberg School of Public Health
The Dang lab contributed to defining the function of the MYC oncogene including establishing the first mechanistic link between MYC and cellular energy metabolism. This foundational concept …
Chi V. Dang - Google Scholar
Chi V. Dang. Ludwig Institute for Cancer Research, Johns Hopkins University School of Medicine. Verified email at jhmi.edu. cancer biology. Articles Cited by Public access. Title. ... CV Dang, …
Chi Van Dang, MD, PhD - Perelman School of Medicine at the …
Zhang L, Peng D, Sood AK, Dang CV, Zhong X.: Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs as Novel Biomarkers and Potential Therapeutic Targets for Cancer. …
Chi DANG | Scientific Director | MD, PhD | Research profile
Chi DANG, Scientific Director | Cited by 65,956 | | Read 449 publications | Contact Chi DANG
Chi Van Dang | Johns Hopkins Bloomberg Distinguished …
Dang hopes that by finding a way to adjust the clock, cancer cells could be made more sensitive to therapy. Dang joined Johns Hopkins University as a Bloomberg Distinguished Professor in …